The inaugural episode of the Critical Path Institute (C-Path) podcast serves as a platform to discuss the intersection of drug development, clinical science, and public health. Hosted by CEO Klaus Romero and guest Cheryl Coon, the episode explores how clinical outcome assessments (COAs) are essential in measuring patient experiences and determining drug efficacy.